NCT04374383

Brief Summary

The aim of this study is to evaluate the periodontal outcomes after applying antimicrobial photodynamic therapy with a novel photosensitizer as compared to LASER assisted scaling and root planing alone.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
26

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2019

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 29, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 5, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

May 7, 2020

Status Verified

May 1, 2020

Enrollment Period

1.4 years

First QC Date

April 29, 2020

Last Update Submit

May 5, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Release profile of the drug

    Release profile of the drug in Gingival Crevicular Fluid (GCF) samples will be evaluated through biochemical testing kits.

    Change from baseline to 7-days.

  • probing pocket depths (PPD)

    Assessment of probing pocket depths (PPD, in mm) by using a manual periodontal probe on six sites (mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual and distolingual) will be performed.

    Change from baseline to 6-months.

  • clinical attachment level (CAL)

    Assessment of clinical attachment level (CAL, in mm) by using a manual periodontal probe on six sites (mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual and distolingual) will be performed.

    Change from baseline to 6-months.

Secondary Outcomes (2)

  • plaque index (PI)

    Change from baseline to 6-months.

  • bleeding on probing (BOP)

    Change from baseline to 6-months.

Study Arms (2)

main treatment group

EXPERIMENTAL

LASER assisted SRP followed by antimicrobial photodynamic therapy with a novel photosensitizer dye Phthalocyanine

Drug: Phthalocyanine DyeDrug: LASER assisted SRP

control group

PLACEBO COMPARATOR

LASER assisted SRP

Drug: LASER assisted SRP

Interventions

following LASER assisted SRP, a novel photosensitizer phthalocyanine dye will be placed

Also known as: Experimental group
main treatment group

LASER assisted SRP will be carried

Also known as: Control group
control groupmain treatment group

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Systemically healthy male and female patients of age 30-60 years with generalized probing pocket depths (PPD) indicative of chronic periodontitis and with atleast two sites with PPD ≥5mm in each quadrant

You may not qualify if:

  • Medically compromised patients, Subjects with a history of periodontal intervention within 6 months of the commencement of the study and smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

R V Chandra

Hyderabad, Telangana, 509002, India

RECRUITING

SVS Institute of Dental Sciences

Hyderabad, Telangana, 509002, India

RECRUITING

MeSH Terms

Conditions

PeriodontitisAlveolar Bone Loss

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesBone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal Atrophy

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

RVchandra, MDS; DNB

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary Investigator

Study Record Dates

First Submitted

April 29, 2020

First Posted

May 5, 2020

Study Start

June 1, 2019

Primary Completion

November 1, 2020

Study Completion

November 1, 2021

Last Updated

May 7, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations